Literature DB >> 17728557

Medical costs of glaucoma and ocular hypertension in Italian referral centres: a prospective study.

Daniela Koleva1, Nicola Motterlini, Mauro Schiavone, Livio Garattini.   

Abstract

AIM: This study analyzes the resource utilization and costs of ocular hypertension and glaucoma (staged by severity) in Italian ophthalmology departments.
METHODS: The project was a multi-centre observational study conducted in 17 Italian ophthalmology departments throughout the country. A total of 659 patients were recruited and followed prospectively for 1 year. For the purpose of analysis, the patients were divided into 3 groups according to the severity at onset: ocular hypertension, glaucoma and advanced glaucoma.
RESULTS: The subgroups differed significantly in the main demographic and clinical variables. As expected, greater severity was associated with older mean age and worse visual acuity, and with higher resource consumption and costs. The annual average cost per patient was EUR 788.7 and rose significantly with disease severity (EUR 572.0 for ocular hypertension, EUR 734.3 for glaucoma and EUR 1,054.9 for advanced glaucoma). Drugs and specialist consultations were by far the largest cost components.
CONCLUSIONS: This study offers some information on the medical costs of glaucoma in Italy potentially useful for decision-making in the health care services. Health care resources and costs increased with disease severity. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17728557     DOI: 10.1159/000104765

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  5 in total

1.  Direct cost and predictive factors for treatment in patients with ocular hypertension or early, moderate and advanced primary open-angle glaucoma: the CoGIS study in Germany.

Authors:  Katrin Lorenz; Christian Wolfram; Lusine Breitscheidel; Margarita Shlaen; Yves Verboven; Norbert Pfeiffer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-04-30       Impact factor: 3.117

2.  The invisible costs of obstructive sleep apnea (OSA): Systematic review and cost-of-illness analysis.

Authors:  Ludovica Borsoi; Patrizio Armeni; Gleb Donin; Francesco Costa; Luigi Ferini-Strambi
Journal:  PLoS One       Date:  2022-05-20       Impact factor: 3.752

Review 3.  Cost of illness of glaucoma: a critical and systematic review.

Authors:  Richard G Fiscella; Jeff Lee; Elizabeth J H Davis; John Walt
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

4.  Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry.

Authors:  Giorgio Walter Canonica; Giorgio Lorenzo Colombo; Giacomo Matteo Bruno; Sergio Di Matteo; Chiara Martinotti; Francesco Blasi; Caterina Bucca; Nunzio Crimi; Pierluigi Paggiaro; Girolamo Pelaia; Giovanni Passalaqua; Gianenrico Senna; Enrico Heffler
Journal:  World Allergy Organ J       Date:  2019-01-26       Impact factor: 4.084

5.  Comparing the long-term impact on health care resources utilization and costs due to various single-piece acrylic monofocal intraocular lens implantation during cataract surgery: a cost-consequence analysis for the United Kingdom, Italy, and Denmark.

Authors:  Mukesh Dhariwal; Christine Bouchet; Shantanu Jawla
Journal:  Clin Ophthalmol       Date:  2019-01-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.